Results 131 to 140 of about 2,933 (228)

The era of combination of nephroprotective agents in CKD is there. [PDF]

Nephrol Dial Transplant
Jadoul M, Rossing P.
europepmc   +1 more source

Integrating Renal and Metabolic Parameters into a Derived Risk Score for Hyperuricemia in Uncontrolled Type 2 Diabetes: A Retrospective Cross-Sectional Study in Northwest Romania. [PDF]

Medicina (Kaunas)
Paduraru L, Zaha DC, Ghitea TC, Fodor R, Vesa CM, Popoviciu MS.   +5 more
europepmc   +1 more source

Molecular mechanism of drug inhibition of URAT1. [PDF]

Nat Commun
Yu Z, Hu T, Su J, Zhao J, Li R, Ma Q, Chen Q, Bai Q, Dong Y, Yuan P, Li N, Zhang XC, Zhao Y.   +12 more
europepmc   +1 more source

New Insights into Uric Acid Metabolism in the Pathophysiology of Ischaemic Heart Disease. [PDF]

Eur Cardiol
Piani F, Annesi L, Borghi C.
europepmc   +1 more source

<i>Monascus</i> Yellow Pigments Ameliorate Hyperuricemia via Dual Mechanisms: Xanthine Oxidase Inhibition and Uric Acid Transporter Modulation (ABCG2, URAT1, and GLUT9). [PDF]

Foods
Xue F, Zhu R, Li J, Liu Z, Niu L, Chen W, Wang C, Zheng J.   +7 more
europepmc   +1 more source

Gout management: Patent analytics and computational drug design explores URAT1 inhibitors landscape. [PDF]

PLoS One
Zhang J, Hong L, Xu W, Zhang X, Fu H, Song X, Zhao J.   +6 more
europepmc   +1 more source

Comparative assessment of the effects of dotinurad and febuxostat on the renal function in chronic kidney disease patients with hyperuricemia. [PDF]

Sci Rep
Takata T, Taniguchi S, Mae Y, Kageyama K, Fujino Y, Iyama T, Hikita K, Sugihara T, Isomoto H.   +8 more
europepmc   +1 more source

Knowledge and practice of gout treatment recommendations by primary health care physicians in Saudi Arabia: A cross-sectional study across five different regions. [PDF]

Medicine (Baltimore)
Alharbi S, Alharthi N, Almuteri D, Jan R, Alsaedi S, Alwakeel A, Alhumaidi N.   +6 more
europepmc   +1 more source

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial. [PDF]

Nephrol Dial Transplant
Mayne KJ, Sardell RJ, Staplin N, Judge PK, Zhu D, Sammons E, Cherney DZI, Green JB, Levin A, Pontremoli R, Hauske SJ, Emberson J, Preiss D, Landray MJ, Baigent C, Wanner C, Haynes R, Herrington WG, EMPA-KIDNEY Collaborative Group .   +18 more
europepmc   +1 more source

Hyperuricemia and its related diseases: mechanisms and advances in therapy. [PDF]

Signal Transduct Target Ther
Du L, Zong Y, Li H, Wang Q, Xie L, Yang B, Pang Y, Zhang C, Zhong Z, Gao J.   +9 more
europepmc   +1 more source